Sacubitril clinical trials
Also written AHU377.
How each study uses sacubitril is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sacubitril studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 7 Jul 2015 · ENTRESTO · NDA 207620 (FDA, Drugs@FDA; in a combination)
- European Union
- 19 Nov 2015 · Entresto · EMEA/H/C/004062 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
48 studies that test it; most in 2019 (6)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 38
Novartis Pharmaceuticals (8) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (2) · Ruijin Hospital (2) · Brigham and Women's Hospital (2) · RenJi Hospital (2) · National Heart Institute, Egypt (1) · University Clinical Hospital Mostar (1) · Torbjorn Omland (1)
Often tested with
Tested in the same studies.
Valsartan (44) · Losartan (3) · Amlodipine (2) · Sacubitril valsartan sodium hydrate (2) · Sacubitril valsartan (2) · Bisoprolol (2) · Nebivolol (1) · Carvedilol (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test sacubitril, phase 3 first.
- Apr 2027Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionPhase 3 · Puerta de Hierro University Hospital
- Nov 2026Sacubitril/Allisartan for Hypertensive Patients With Overweight or ObesityPhase 4 · Jing Liu
- Dec 2026Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery DiseasePhase 4 · China National Center for Cardiovascular Diseases
- Apr 2027Enhancing the Natriuretic Peptide System in HFpEFPhase 1/2 · Horng Chen
Studies
Open first, then newest update. How each study uses sacubitril is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 48
- Enhancing the Natriuretic Peptide System in HFpEFEnrolling by invitationPhase 1/2Horng ChenNCT05279742Written as Sacubitril/Valsartan
- Sacubitril/Valsartan vs Standard Treatment for Preventing Atrial Fibrillation Recurrence After Catheter Ablation in Persistent Atrial Fibrillation Patients With Without HypertensionNot yet recruitingPhase 4Ruijin HospitalNCT07910058Written as Sacubitril/Valsartan
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo CardiomyopathyRecruitingNot applicableUniversity of EdinburghNCT07491718Written as sacubitril/ valsartan
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection FractionRecruitingPhase 3John Paul II Hospital, KrakowNCT05508035Written as Sacubitril / Valsartan
- Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural TanzaniaRecruitingPhase 4Martin RohacekNCT06704633Written as Sacubitril / Valsartan Oral Tablet
- Sacubitril/Allisartan for Hypertensive Patients With Overweight or ObesityNot yet recruitingPhase 4Jing LiuNCT07241338Written as sacubitril/allisartan
- Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection FractionRecruitingNot applicableKafrelsheikh UniversityNCT07192341Written as Sacubitril/Valsartan
- Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery DiseaseRecruitingPhase 4China National Center for Cardiovascular DiseasesNCT06917664Written as sacubitril/valsartan
- Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionNot yet recruitingPhase 3Puerta de Hierro University HospitalNCT06712030Written as Sacubitril / Valsartan
- Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic NephropathyNot yet recruitingPhase 4Sichuan Academy of Medical SciencesNCT06501651Written as Sacubitril/Valsartan
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingPhase 4Heart Center Research, LLCNCT06218199Written as sacubitril/valsartan
- Determination of Drug Levels for Pharmacotherapy of Heart FailureNot yet recruitingPhase 4University Hospital OstravaNCT06035978Written as Valsartan and Sacubitril
- Glucagon-like Peptide-1 Metabolism and Acute Neprilysin InhibitionWithdrawnPhase 3University of PennsylvaniaNCT03508739Written as Sacubitril/Valsartan 200mg (blinded)
- Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart FailureCompletedPhase 2/3National Heart Institute, EgyptNCT07023016Written as Sacubitril / Valsartan
- Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/AllisartanCompletedPhase 3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07704697Written as Experimental: Sacubitril/Allisartan and Amlodipine Group
- Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With AmlodipineCompletedPhase 3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07704684Written as Experimental: Sacubitril/Allisartan and Amlodipine Group
- The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEFCompletedPhase 4University Clinical Hospital MostarNCT07417215Written as Sacubitril / Valsartan
- Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCCCompletedPhase 4Novartis PharmaceuticalsNCT04023227Written as Sacubitril/valsartan
- A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 StudyCompletedPhase 3Novartis PharmaceuticalsNCT06149104Written as sacubitril/valsartan
- Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HFCompletedPhase 3Novartis PharmaceuticalsNCT03785405Written as sacubitril/valsartan
See all 48 studies that test sacubitril →
Given beside what is tested · 3 — sacubitril is usual care or a partner of the new treatment
- Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyRecruitingPhase 4Kyungsub SongNCT07572032Written as Sacubitril / Valsartan
- Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG TrialRecruitingPhase 1Khawaja Danish AliNCT07444398Written as Sacubitril / Valsartan
- Multimodal Analgesia for CholecystectomyCompletedPhase 3Gangnam Severance HospitalNCT04788654Written as Celebrex, acetaminophen, and dexamethasone
As the comparator · 4 — what is tested is compared with sacubitril
- QR12000 Compound Tablets in Patients with Moderate to Severe Essential HypertensionNot yet recruitingPhase 3Wuhan Createrna Science and Technology Co., LtdNCT06716970Written as Sacubitril/valsartan 200mg
- A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential HypertensionCompletedPhase 2Wuhan Createrna Science and Technology Co., LtdNCT07700875Written as Sacubitril / valsartan 200 mg
- A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart FailureTerminatedPhase 2Novartis PharmaceuticalsNCT06142383Written as Sacubitril/valsartan
- The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm InfantsStatus unknownPhase 2Hospital General Naval de Alta Especialidad - Escuela Medico NavalNCT02602054Written as Control group
What changed recently
From the registry's own updates since Oct 18, 2026.
Codes
What other systems call sacubitril · ClinicalTrials.gg INT001624
- MeSH (NLM) C000717211sacubitrilOne source NLM
- UNII (FDA) 17ERJ0MKGISACUBITRILConfirmed FDA, NLM, Wikidata
- RxNorm 1656328Confirmed FDA, Wikidata
- Wikidata Q17811448sacubitrilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152281SacubitrilOne source FDA
- DrugBank DB09292One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000717211 | sacubitril | One source NLM |
| UNII (FDA) | 17ERJ0MKGI | SACUBITRIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1656328 | — | Confirmed FDA, Wikidata |
| Wikidata | Q17811448 | sacubitril | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152281 | Sacubitril | One source FDA |
| DrugBank | DB09292 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.